Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021

SELL
$49.14 - $59.89 $13,808 - $16,829
-281 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$42.19 - $51.5 $34,005 - $41,509
-806 Reduced 74.15%
281 $14,000
Q3 2020

Oct 27, 2020

BUY
$35.33 - $51.04 $38,403 - $55,480
1,087 New
1,087 $55,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.